Skip to main content

Table 1 Characteristics of 135 patients with advanced-stage classic Hodgkin lymphoma and 221 healthy controls

From: The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma

 

Patients n = 135

Controls n = 221

p value

Sex, no. (%)

    

  Male

67

(49.6)

104 (47.1)

NS

  Female

68

(50.4)

117 (52.9)

NS

Age at diagnosis, mean (range)

34

(15–69)

35 (25–55)

NS

Disease subtype, no. (%)

    

  Nodular sclerosing

108

(80.0)

  

  Mixed-cellularity

14

(10.4)

  

  Lymphocyte-rich

9

(6.7)

  

  Lymphocyte-depleted

4

(2.9)

  

Albumin, g/dl, mean (range)

3.8

(2.2–5.1)

  

Hemoglobin, g/dl, mean (range)

13.0

(8.3–14.2)

  

Lymphocytes, ×103/μL, mean (range)

1.75

(0.3–4.9)

  

Neutrophils, ×103/μL, mean (range)

8.55

(2.1–35.8)

  

Bulky mass, no. (%)

55

(40.7)

  

“B” symptoms, no. (%)

73

(54.1)

  

Extranodal extension, no. (%)

42

(31.1)

  

IPS score ≥ 4 (unfavorable in advanced stages)

39

(28.9)

  

Ann Arbor stage 1–2a, no. (%)

0

(0)

  

  Stage 2b, no. (%)

57

(42.2)

  

  Stage 3, no. (%)

45

(33.3)

  

  Stage 4, no. (%)

33

(24.5)

  
  1. NS not significant